Cubist upgraded to Hold from Sell at Cantor Cantor upgraded Cubist to Hold citing the playing out of negative catalysts following the company's Q4 results and 2013 outlook. The firm raised its price target for shares to $38 from $37.
News For CBST From The Last 14 Days
Check below for free stories on CBST the last two weeks.
Cubist potential strategic buyer may be willing to pay $95 or more, says Cowen Cowen noted Cubist's Cubicin sales were light during the quarter as management cited seasonality. The firm believes the miss is a non-event and sees value creation for shareholders entering at these levels. Cowen continues to believe Cubist should and will be acquired by a strategic buyer with a U.S. and International hospital sales force presence and could potentially pay $95 or more for the company. Shares are Outperform rated with a $80 price target.